FIRS HOUSE SURGERY — All Prescriptions & Medications — Page 9
Practice Code: D81028 | CAMBRIDGE, CB24 9NP
Showing results 401-450 of 644
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Erythromycin | 38 | 1,380 | £619 | +179.8% ▲ |
| Hyoscine hydrobromide | 37 | 1,268 | £215 | +8.4% ▲ |
| Coal tar | 37 | 9,875 | £201 | -49.2% ▼ |
| 37 | 2,662 | £5.0K | -7.2% ▼ | |
| Olmesartan medoxomil | 36 | 1,652 | £106 | -47.7% ▼ |
| Co-dydramol (Dihydrocodeine/paracetamol) | 36 | 4,154 | £347 | -80.0% ▼ |
| Biphasic insulin lispro | 36 | 359 | £2.2K | -16.1% ▼ |
| Ivermectin | 36 | 1,680 | £977 | +69.3% ▲ |
| Fluticasone/umeclidinium/vilanterol | 35 | 35 | £1.5K | -85.1% ▼ |
| Methenamine hippurate | 35 | 2,248 | £502 | -61.5% ▼ |
| Levonorgestrel | 35 | 35 | £3.0K | -7.3% ▼ |
| Permethrin | 35 | 1,770 | £503 | -7.1% ▼ |
| Colestyramine | 34 | 2,666 | £1.0K | +18.0% ▲ |
| Glucagon | 34 | 40 | £1.1K | +123.5% ▲ |
| Valsartan | 33 | 1,484 | £357 | -44.0% ▼ |
| Theophylline | 33 | 2,520 | £1.3K | -60.5% ▼ |
| Amantadine hydrochloride | 33 | 2,604 | £681 | +18.5% ▲ |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 33 | 27.4K | £426 | +44.0% ▲ |
| Chlorhexidine gluconate | 33 | 12.5K | £254 | +11.7% ▲ |
| Terbutaline sulphate | 32 | 34 | £268 | -41.0% ▼ |
| Fluorometholone | 32 | 270 | £81 | +122.1% ▲ |
| 32 | 720 | £87 | +19.1% ▲ | |
| 32 | 1,210 | £7.9K | +150.5% ▲ | |
| Zinc oxide | 31 | 717 | £89 | +49.8% ▲ |
| Glyceryl trinitrate | 31 | 930 | £1.2K | +133.3% ▲ |
| Metoprolol tartrate | 31 | 1,568 | £153 | -38.9% ▼ |
| Fluvastatin sodium | 31 | 1,596 | £560 | +34.0% ▲ |
| Cinnarizine | 31 | 3,556 | £156 | -33.8% ▼ |
| Adapalene | 31 | 1,575 | £547 | +41.6% ▲ |
| Prednisolone | 30 | 733 | £81 | -58.3% ▼ |
| Colesevelam hydrochloride | 30 | 7,020 | £2.9K | -20.9% ▼ |
| Pyridoxine hydrochloride | 30 | 980 | £411 | +39.6% ▲ |
| 30 | 57 | £150 | -26.3% ▼ | |
| 30 | 1,753 | £561 | +55.2% ▲ | |
| Amiloride hydrochloride | 29 | 1,652 | £817 | +15.2% ▲ |
| Cyclizine lactate | 29 | 380 | £361 | +93.3% ▲ |
| Heparinoid | 29 | 3,625 | £198 | +10.6% ▲ |
| 29 | 84 | £768 | +4.2% ▲ | |
| 29 | 1,080 | £4.9K | +30.0% ▲ | |
| Lacosamide | 28 | 10.2K | £1.5K | -47.9% ▼ |
| Trihexyphenidyl hydrochloride | 28 | 1,526 | £71 | -1.3% vs avg |
| Liothyronine sodium | 28 | 1,820 | £5.8K | +31.3% ▲ |
| Dutasteride | 28 | 1,150 | £67 | -45.5% ▼ |
| Leuprorelin acetate | 28 | 28 | £4.2K | -39.6% ▼ |
| 28 | 93 | £916 | -9.7% ▼ | |
| 28 | 1,160 | £4.5K | +8.3% ▲ | |
| Formoterol fumarate | 27 | 33 | £778 | +88.3% ▲ |
| Guanfacine | 27 | 756 | £1.5K | +5.1% ▲ |
| Duloxetine hydrochloride | 27 | 1,672 | £429 | -47.3% ▼ |
| Atropine sulfate | 27 | 270 | £3.2K | +111.9% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.